Azza Abdelgawad

Freie Universität Berlin — Germany

Medicine · Health Sciences

17h-index1.4kcitations36works7.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(22), COVID-19 Clinical Research Studies(13), Herpesvirus Infections and Treatments(12), Animal Virus Infections Studies(8), Animal Disease Management and Epidemiology(7)

Publications36 total

Severe Elephant Endotheliotropic Herpesvirus 6 Associated Disease in Two African Elephants Under Human Care in Austria
Animals·2025· 1 citedOpen Access
Fatal infection caused by a genetically distinct elephant endotheliotropic herpesvirus type 5 in a captive Asian elephant in Germany
Virology Journal·2024· 2 citedOpen Access
First fatal elephant endotheliotropic herpesvirus type 5 infection in a captive Asian elephant in Germany
2024Open Access
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Nature Communications·2024· 28 citedOpen Access
A systematic analysis of anthocyanins inhibiting human, murine, and equine herpesviruses
Phytomedicine·2023· 1 cited
A non-transmissible live attenuated SARS-CoV-2 vaccine
Molecular Therapy·2023· 17 citedOpen Access
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
Nature Microbiology·2023· 76 citedOpen Access
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
iScience·2023· 3 citedOpen Access
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
Nature Biotechnology·2022· 56 citedOpen Access
Body temperature variation controls pre-mRNA processing and transcription of antiviral genes and SARS-CoV-2 replication
Nucleic Acids Research·2022· 14 citedOpen Access
A live attenuated vaccine confers superior mucosal and systemic immunity to SARS-CoV-2 variants
2022· 3 citedOpen Access
Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics
Molecular Therapy·2022· 33 citedOpen Access
Preclinial Safety and Efficacy of a Therapeutic Antibody That Targets SARS-CoV-2 at the Sotrovimab Face But is Escaped by Omicron
SSRN Electronic Journal·2022Open Access
Insights into standards of care – dexamethasone and antibodies against COVID-19 in hamster models
2021Open Access
Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)
Science Advances·2021· 44 citedOpen Access
Deciphering the Role of Humoral and Cellular Immune Responses in Different COVID-19 Vaccines—A Comparison of Vaccine Candidate Genes in Roborovski Dwarf Hamsters
Viruses·2021· 7 citedOpen Access
Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding
Cell Reports·2021· 71 citedOpen Access
Ensovibep, a novel trispecific DARPin candidate that protects against SARS-CoV-2 variants
2021· 17 citedOpen Access
Development of Safe and Highly Protective Live-Attenuated SARS-CoV-2 Vaccine Candidates by Genome Recoding
SSRN Electronic Journal·2021· 5 citedOpen Access
The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection
Cell Reports·2020· 100 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Jakob Trimpert(27), Achim D. Gruber(20), Nikolaus Osterrieder(20), Julia M. Adler(14), Daria Vladimirova(13), Dušan Kunec(11), Kristina Dietert(10), Luca D. Bertzbach(10), Kathrin Eschke(9), Jakob Kreye(7), S. Momsen Reincke(7), Martin Witzenrath(7), Harald Prüß(7), Leif Erik Sander(6), Judith Bushe(6), Hans‐Christian Kornau(5), Victor M. Corman(5), Dietmar Schmitz(5), Lara M. Jeworowski(5), Marie Luisa Schmidt(5)